These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6770941)

  • 21. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rh(D)-immunization in pregnancy].
    Nordhagen R
    Tidsskr Nor Laegeforen; 1981 May; 101(15):934-7. PubMed ID: 6791303
    [No Abstract]   [Full Text] [Related]  

  • 23. [Detection of Rh antibodies in pregnancy].
    ZACHARIAS K
    Dtsch Gesundheitsw; 1957 May; 12(19):581-4. PubMed ID: 13447473
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhesus and other blood group incompatibilities in pregnancy.
    Gunston KD; Botha I
    S Afr Med J; 1980 Oct; 58(16):639-41. PubMed ID: 6775377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 26. The introduction of human monoclonal anti-D for therapeutic use.
    Fletcher A; Thomson A
    Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 28. [Occurrence of hemolytic disease of the newborn caused by irregular antibodies].
    Mickley H
    Ugeskr Laeger; 1983 Jun; 145(23):1763-5. PubMed ID: 6410568
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 30. Is the recommended minimum dose of anti-D adequate considering the rise in obesity?
    Regan FA; Naftalin J; Springer V; Paterson-Brown S
    Transfus Med; 2008 Aug; 18(4):266-8. PubMed ID: 18783586
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemolytic disease of the newborn from anti-E. A case report.
    Strohm PL; Iams JD; Kennedy MS
    J Reprod Med; 1988 Apr; 33(4):404-6. PubMed ID: 3130484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of rhesus (D) immunisation--some causes of failure in Northern Ireland.
    McClelland WM; McLoughlin KG
    Ulster Med J; 1980; 49(2):148-52. PubMed ID: 6777935
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial: Prevention of rhesus immunization in Australia.
    Med J Aust; 1975 Aug; 2(7):241. PubMed ID: 808696
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of a rapid antenatal Rh test on laboratory testing.
    Smart EA; Milner LV
    S Afr Med J; 1993 Dec; 83(12):922. PubMed ID: 8115932
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunological aspects of the prevention of hemolytic disease of the newborn].
    Antonian AK
    Zh Eksp Klin Med; 1973; 13(6):44-9. PubMed ID: 4215267
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):563-5. PubMed ID: 6788016
    [No Abstract]   [Full Text] [Related]  

  • 37. Sound boards. Rh immunoprophylaxis: is antepartum therapy desirable?
    Nusbacher J; Bove JR
    N Engl J Med; 1980 Oct; 303(16):935-7. PubMed ID: 6774249
    [No Abstract]   [Full Text] [Related]  

  • 38. The prenatal use of RhO(D) immune globulin.
    Hammer RM; Bower EJ; Messina LJ
    MCN Am J Matern Child Nurs; 1984; 9(1):29-31. PubMed ID: 6422184
    [No Abstract]   [Full Text] [Related]  

  • 39. Economics of anti-rhesus prophylaxis in an African population.
    Verkuyl DA
    Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.